Stephen A. Spector

发表

The Safety of Discontinuation of Maintenance Therapy for Cytomegalovirus (CMV) Retinitis and Incidence of Immune Recovery Uveitis Following Potent Antiretroviral Therapy

S. Spector, K. Squires, M. Jacobson, 2005, HIV clinical trials.

High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection.

T. Greenough, D. Havlir, S. Spector, 1995, The Journal of infectious diseases.

Diagnosis of human cytomegalovirus central nervous system disease in AIDS patients by DNA amplification from cerebrospinal fluid.

S. Spector, D. Wolf, Stephen A. Spector, 1992, The Journal of infectious diseases.

Acquired Immunodeficiency Syndrome: Mangnetic Resonance Patterns of Brain Involvement With Pathologic Correlation

D. Richman, J. Hesselink, R. Teschke, 1988 .

Patterns of plasma human immunodeficiency virus type 1 RNA response to highly active antiretroviral therapy in infected children.

L. Mofenson, S. Spector, C. Fletcher, 2000, The Journal of infectious diseases.

Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy

J. Corbeil, D. Richman, D. Havlir, 1994, Journal of virology.

Phase I/II evaluation of nevirapine alone and in combination with zidovudine for infection with human immunodeficiency virus.

T. Greenough, D. Havlir, S. Spector, 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

A randomized trial of the activity and safety of Ro 24-7429 (Tat antagonist) versus nucleoside for human immunodeficiency virus infection. The AIDS Clinical Trials Group 213 Team.

C. Pettinelli, Stephen A. Spector, Paul S. Lietman, 1995, The Journal of infectious diseases.

Summary of the International Consensus Symposium on Advances in the Diagnosis, Treatment and Prophylaxis and Cytomegalovirus Infection.

C. Katlama, P. Griffiths, S. Spector, 1996, Antiviral Research.

A pilot study of low-dose zidovudine in human immunodeficiency virus infection.

D. Richman, C. Pettinelli, S. Spector, 1990, The New England journal of medicine.

Virologic characterization of primary human immunodeficiency virus type 1 infection in a health care worker following needlestick injury.

S. Spector, S. Kwok, N. McKinney, 1995, The Journal of infectious diseases.

Low Rate of CMV End-Organ Disease in HIV-Infected Patients Despite Low CD4+ Cell Counts and CMV Viremia: Results of ACTG Protocol A5030

C. Crumpacker, S. Spector, D. Jabs, 2009, HIV clinical trials.

Spectrum and treatment of cytomegalovirus disease in persons with AIDS.

Stephen A. Spector, 1996, Journal of the International Association of Physicians in AIDS Care.

The CCR5Delta32 allele slows disease progression of human immunodeficiency virus-1-infected children receiving antiretroviral treatment.

S. Spector, J. Englund, C. Baker, 2000, The Journal of infectious diseases.

Quality of life in a placebo-controlled trial of zidovudine in patients with AIDS and AIDS-related complex.

I Grant, J H Atkinson, A. Wu, 1990, Journal of acquired immune deficiency syndromes.

The evolution of lymphadenopathy and hypergammaglobulinemia are evidence for early and sustained polyclonal B lymphocyte activation during human immunodeficiency virus infection.

I. Abramson, J. McCutchan, S. Spector, 1991, The Journal of infectious diseases.

Detection of human immunodeficiency virus type 1 in AIDS patients using amplification-mediated hybridization analyses: reproducibility and quantitative limitations.

Srinka Ghosh, E. Fahy, P. Kao, 1990, The Journal of infectious diseases.

Summary of the II International Symposium on Cytomegalovirus.

B. Gazzard, P. Griffiths, S. Spector, 1998, Antiviral research.

Virologic and immunologic response to nucleoside reverse-transcriptase inhibitor therapy among human immunodeficiency virus-infected infants and children.

S. Spector, T. Schutzbank, J. Englund, 1999, The Journal of infectious diseases.